在移动健康随机对照试验中选择和描述对照条件:一种拟议的类型学
Simon B Goldberg1,2, Shufang Sun3,4,5, Per Carlbring6
1Department of Counseling Psychology, University of Wisconsin-Madison, Madison, WI, USA. sbgoldberg@wisc.edu.
NPJ digital medicine
|September 29, 2023
概括
这项研究引入了移动健康 (mHealth) 随机对照试验 (RCT) 的新类型,以标准化控制条件类型. 这一框架提高了mHealth研究结果的科学严谨性和可解释性.
科学领域:
- 数字健康数字健康
- 心理健康研究 心理健康研究
- 行为科学 行为科学
- 临床试验方法论 临床试验方法论
背景情况:
- 移动健康 (mHealth) 工具在精神和行为健康的随机对照试验 (RCT) 中得到广泛测试.
- 在mHealth RCT中不同的控制条件使科学解释和元分析复杂化.
- 在研究中不一致的命名方式阻碍了mHealth研究证据的综合.
研究的目的:
- 建议在mHealth RCT中对控制条件类型进行标准化类型.
- 提高报告和分析移动健康干预研究的清晰度和一致性.
- 为了促进从mHealth比较有效性研究中得出更准确的科学推断.
主要方法:
- 开发一种新型类型,定义11个不同的控制条件类型,用于mHealth RCT.
- 确定区分控制条件的关键维度.
- 创建一个决策树,以帮助选择和确定控制类型.
- 提出五级比较强度分级和四个简化分类方案.
主要成果:
- 拟议的类型为在mHealth RCT中对控制条件进行分类提供了一个结构化的方法.
- 该框架澄清了与不同对照对比可能的科学推断.
- 讨论在定义,在道德上实施和对控制条件进行元分析方面尚未解决的问题.
结论:
- 标准化的类型学对于推动对移动健康干预措施的科学理解至关重要.
- 控制条件的一致分类将提高移动健康研究的质量和可比性.
- 需要进一步的工作来解决mHealth控制条件研究中的定义,伦理和元分析挑战.
相关概念视频
Controls in Experiments
7.8K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
7.8K
Randomized Experiments
7.0K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
7.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
145
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
145
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Hazard Ratio
152
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
152


